EDGAR Filing Documents for 0001193125-15-104674

Form 8-K - Current report:

SEC Accession No. 0001193125-15-104674

Filing Date

2015-03-25

Accepted

2015-03-25 13:06:06

Documents

Period of Report

2015-03-25

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d896511d8k.htm	8-K	14446
2	EX-99.1	d896511dex991.htm	EX-99.1	11524
3	GRAPHIC	g896511g44m77.jpg	GRAPHIC	2650
	Complete submission text file	0001193125-15-104674.txt		30919

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8

Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200

TEKMIRA PHARMACEUTICALS Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 15724076
SIC: 2834 Pharmaceutical Preparations